Publications by authors named "William Potter"

Claim this Profile
P
Plasma biomarkers in neuropsychiatric syndromes: A narrative review.
Zahinoor Ismail, Dylan X Guan, Ganesh M Babulal, James R Bateman, Marc Cantillon, William Z Potter

J Alzheimers Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Alzheimer's disease-translating biomarker insights across CNS diseases.
Linda S Brady, Simin Mahinrad, Rebecca M Edelmayer, William Z Potter, Samantha J Hutten

Sci Transl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks.
Marta Milà-Alomà, Duygu Tosun, Suzanne E Schindler, Isabella Hausle, Kellen K Petersen, William Z Potter

Ann Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohorts.
Luyao Wang, Wenjing Hu, Fan Dong, Can Sheng, Jinglong Wu, William Potter

Geroscience· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The GREENBEAN checklist for reporting studies evaluating the effectiveness of EEG-based biomarkers.
Joshua B Ewen, Claudio Babiloni, Gary S Collins, Lauren E Ethridge, Jean Gotman, William Z Potter

Clin Neurophysiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The origins of ADNI.
William Z Potter, Neil S Buckholtz, Steven M Paul

Alzheimers Dement· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-head comparison of leading blood tests for Alzheimer's disease pathology.
Suzanne E Schindler, Kellen K Petersen, Benjamin Saef, Duygu Tosun, Leslie M Shaw, William Z Potter

Alzheimers Dement· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public-Private Partnerships for Neuropsychiatric Drug Development: A Perspective.
William Z Potter

Adv Neurobiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of changes in Alzheimer's disease plasma biomarkers as assessed by amyloid and tau PET clocks.
Marta Milà-Alomà, Duygu Tosun, Suzanne E Schindler, Zachary Hausle, Yan Li, William Z Potter

medRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical breakage, slippage and acceptability of two commercial ultra-thin polyurethane male condoms compared to a commercial thin latex condom: a randomised, masked, 3 way crossover, multi centre controlled study (SAGCS 2).
William Potter, Grant Burt, Terri Walsh

Reprod Health· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-head comparison of leading blood tests for Alzheimer's disease pathology.
Suzanne E Schindler, Kellen K Petersen, Benjamin Saef, Duygu Tosun, Leslie M Shaw, William Z Potter

medRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finding new and better treatments for psychiatric disorders.
Steven M Paul, William Z Potter

Neuropsychopharmacology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and Challenges for a New Instrument for Remote Measurement of Negative Symptoms.
David Gordon Daniel, Alex S Cohen, Philip D Harvey, Dawn I Velligan, William Z Potter

Schizophr Bull Open· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shifting the trajectory of therapeutic development for neurological and psychiatric disorders.
Dimitri Krainc, William J Martin, Bradford Casey, Frances E Jensen, Sarah Tishkoff, William Z Potter

Sci Transl Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using latent profile analyses to classify subjects with anhedonia based on reward-related measures obtained in the FAST-MAS study.
Sabrina M Darrow, Diego A Pizzagalli, Moria Smoski, Sanjay J Mathew, John Nurnberger, William Z Potter

J Affect Disord· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A primary microcephaly-associated sas-6 mutation perturbs centrosome duplication, dendrite morphogenesis, and ciliogenesis in Caenorhabditis elegans.
Mary Bergwell, Amy Smith, Ellie Smith, Carter Dierlam, Ramon Duran, William Potter

Genetics· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity.
Stephen Zicha, Randall J Bateman, Leslie M Shaw, Henrik Zetterberg, Anthony W Bannon, William Z Potter

Alzheimers Dement· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real changes can enhance information yield on novel psychopharmacologic agents.
William Z Potter

World Psychiatry· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote Assessment of Negative Symptoms of Schizophrenia.
David G Daniel, Alex S Cohen, Dawn Velligan, Phillip D Harvey, Larry Alphs, William Potter

Schizophr Bull Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms.
William Z Potter

J Clin Psychopharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central Nervous System Trial Failures: Using the Fragile X Syndrome-mGluR5 Drug Target to Highlight the Complexities of Translating Preclinical Discoveries Into Human Trials.
Margaret C Grabb, William Z Potter

J Clin Psychopharmacol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease.
Ondrej Libiger, Leslie M Shaw, Mark H Watson, Angus C Nairn, Kelly L Umaña, William Z Potter

Alzheimers Dement· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS).
Diego A Pizzagalli, Moria Smoski, Yuen-Siang Ang, Alexis E Whitton, Gerard Sanacora, William Z Potter

Neuropsychopharmacology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BIOMARKERS AND NEUROBEHAVIORAL DIAGNOSIS.
Joshua B Ewen, William Z Potter, John A Sweeney

Biomark Neuropsychiatry· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NIMH 'Fast-Fail Trials' (FAST) Initiative: Rationale, Promise, and Progress.
Margaret C Grabb, Mi Hillefors, William Z Potter

Pharmaceut Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis